S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:OBIO

Orchestra BioMed (OBIO) Stock Price, News & Analysis

$5.27
-0.04 (-0.75%)
(As of 03/28/2024 ET)
Today's Range
$5.18
$5.62
50-Day Range
$5.00
$9.41
52-Week Range
$4.26
$23.39
Volume
100,172 shs
Average Volume
54,163 shs
Market Capitalization
$188.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.00

Orchestra BioMed MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
222.6% Upside
$17.00 Price Target
Short Interest
Bearish
4.16% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.34mentions of Orchestra BioMed in the last 14 days
Based on 9 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.50) to ($1.46) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.86 out of 5 stars

Medical Sector

674th out of 938 stocks

Surgical & Medical Instruments Industry

69th out of 95 stocks

OBIO stock logo

About Orchestra BioMed Stock (NASDAQ:OBIO)

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a strategic collaboration with Medtronic for the development and commercialization of BackBeat CNT for the treatment of hypertension in patients indicated for a cardiac pacemaker; and a strategic partnership with Terumo Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.

OBIO Stock Price History

OBIO Stock News Headlines

Did you make $29,000 two days with AI options trades?
What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:
Orchestra BioMed (NASDAQ:OBIO) Trading Down 0.7%
Did you make $29,000 two days with AI options trades?
What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:
Orchestra BioMed Holdings Inc OBIO
Orchestra BioMed Holdings, Inc. (OBIO)
Orchestra BioMed Holdings Inc.
See More Headlines
Receive OBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orchestra BioMed and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/28/2024
Next Earnings (Estimated)
5/10/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:OBIO
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$17.00
High Stock Price Target
$20.00
Low Stock Price Target
$14.00
Potential Upside/Downside
+217.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-2,730,000.00
Pretax Margin
-22,322.03%

Debt

Sales & Book Value

Annual Sales
$147,000.00
Book Value
($0.62) per share

Miscellaneous

Free Float
N/A
Market Cap
$191.23 million
Optionable
Not Optionable
Beta
0.19
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. David P. Hochman (Age 49)
    Founder, Chairman of the Board of Directors & CEO
    Comp: $790k
  • Mr. Darren R. Sherman (Age 53)
    Founder, President, COO & Director
    Comp: $790k
  • Mr. Andrew Lawrence Taylor M.B.A. (Age 53)
    Chief Financial Officer
  • Mr. William Reed Little (Age 53)
    Executive VP of Corporate Development & Strategy
  • Dr. Yuval Hay Mika D.Sc
    Ph.D., GM & CTO of Bioelectronic Therapies
  • Dr. George Papandreou Ph.D.
    Senior VP & GM of Focal Therapies
  • Dr. Hans-Peter Stoll M.D.
    Ph.D., Chief Clinical Officer
  • Dr. Avraham Matityahu Fischer M.D. (Age 68)
    Senior Vice President of Medical Affairs & Innovation
  • Mr. Bob Laughner
    Senior Vice President of Regulatory & Quality
  • Mr. Juan Lorenzo
    Senior Vice President of Product Development

OBIO Stock Analysis - Frequently Asked Questions

Should I buy or sell Orchestra BioMed stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Orchestra BioMed in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" OBIO shares.
View OBIO analyst ratings
or view top-rated stocks.

What is Orchestra BioMed's stock price target for 2024?

2 Wall Street research analysts have issued 12 month price objectives for Orchestra BioMed's shares. Their OBIO share price targets range from $14.00 to $20.00. On average, they anticipate the company's stock price to reach $17.00 in the next year. This suggests a possible upside of 222.6% from the stock's current price.
View analysts price targets for OBIO
or view top-rated stocks among Wall Street analysts.

How have OBIO shares performed in 2024?

Orchestra BioMed's stock was trading at $9.13 at the start of the year. Since then, OBIO stock has decreased by 42.3% and is now trading at $5.27.
View the best growth stocks for 2024 here
.

When is Orchestra BioMed's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024.
View our OBIO earnings forecast
.

Who are Orchestra BioMed's major shareholders?

Orchestra BioMed's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (3.43%), Vanguard Group Inc. (3.43%), Price T Rowe Associates Inc. MD (1.74%), Price T Rowe Associates Inc. MD (1.74%), Charles Schwab Investment Management Inc. (0.49%) and Northern Trust Corp (0.40%).

How do I buy shares of Orchestra BioMed?

Shares of OBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:OBIO) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners